| | The Latest in CF Research
| |
The Foundation continues to fund research into phage therapy, the use of specialized viruses that kill specific bacterial strains to treat an infection in a person. As a part of this effort, we awarded $1 million to Felix Biotechnology to develop a novel phage therapy approach to treat chronic Pseudomonas aeruginosa infections in people with cystic fibrosis.
Read more about the award »
| |
You’re invited to join us April 7 and 9 for the fourth annual ResearchCon. During this free, online event, you can learn the basics and the latest around CF science, research, and care from clinicians, researchers, and community members alike. You’ll also hear about the topics that matter most to you, such as Trikafta®, infections, GI, aging with CF, mental health, daily care, and more. Can’t attend live? Register to be notified when all the sessions will be available on YouTube.
RSVP today »
| |
| Join the Collective Voice of the CF Community on the Hill
| |
The CF Foundation is advocating for the PASTEUR Act, a bipartisan piece of legislation that would help to build a sustainable pipeline for antibiotic development. Join us March 17 for our annual Online Day of Action and tell Congress why passing the PASTEUR Act is critical to the fight against antibiotic-resistant infections.
| |
| Register for a Community Webinar in Spanish
| |
If you or your child has cystic fibrosis, register to join us for a community webinar in Spanish on Tuesday, March 22 at 7 p.m. ET . During the webinar, attendees will hear from CF researchers about what causes CF and the importance of CFTR mutations, and have the opportunity to ask their questions live. All those who register will receive a recording of the event. We encourage you to share this event with anyone who might find it valuable.
Save your seat »
| |
|
|
|
|
